However, in AD patients with confirmed neurofibrillary degeneration, BCL2 immunoreactivity decreases, which supports the unclear role of this protein in preventing Aβ-induced apoptosis, including PaPE-1-evoked Bcl2 gene hypermethylation observed in the present study. Here, BCL2 is linked to Alzheimer disease.